Immutep
IMMP
$2.60
Share price
-3.35%
Change (1 day)
54.76%
Change (1 year)
Categories
P/S ratio for Immutep (IMMP)
P/S ratio at the end of 2023: N/A
According to Immutep's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1254030. At the end of 2023 the company had a P/S ratio of N/A.
P/S ratio history for Immutep from 2012 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | N/A | -100% |
| 2022 | > 1000 | |
| 2021 | N/A | -100% |
| 2020 | 10.1 | -98.33% |
| 2019 | 603 | 2047.16% |
| 2018 | 28.1 | |
| 2017 | N/A | -100% |
| 2016 | 483 | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | 4.35 | -100.00% | 🇺🇸 USA |
 FibroGen FGEN | 0.7540 | -100.00% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | 0.1669 | -100.00% | 🇺🇸 USA |